$EW
Edwards Lifesciences Corp Stock $ew

$ew Overview Financials Valuation SEC Filings Company Website

2014 Q2 Form 10-Q Financial Statement

#000104746914006621 Filed on August 04, 2014

Income Statement

Concept	2014 Q2	2013 Q4	2013 Q2
Revenue	$575.1M	$536.0M	$517.2M
YoY Change	11.19%	5.0%	7.3%
Cost Of Revenue	$151.2M	$143.8M	$123.6M
YoY Change	22.33%	14.31%	-4.78%
Gross Profit	$423.9M	$390.5M	$393.6M
YoY Change	7.7%	1.51%	11.75%
Gross Profit Margin	73.71%	72.85%	76.1%
Selling, General & Admin	$215.5M	$186.6M	$186.6M
YoY Change	15.49%	4.89%	2.3%
% of Gross Profit	50.84%	47.78%	47.41%
Research & Development	$89.10M	$78.60M	$80.50M
YoY Change	10.68%	4.94%	8.78%
% of Gross Profit	21.02%	20.13%	20.45%
Depreciation & Amortization	$16.10M	$13.00M	$14.70M
YoY Change	9.52%	-13.91%	5.0%
% of Gross Profit	3.8%	3.33%	3.73%
Operating Expenses	$304.6M	$264.4M	$267.1M
YoY Change	14.04%	4.96%	4.17%
Operating Profit	$119.3M	$126.1M	$126.5M
YoY Change	-5.69%	-5.05%	32.05%
Interest Expense	-$3.100M	-$4.400M	-$400.0K
YoY Change	675.0%	780.0%	-500.0%
% of Operating Profit	-2.6%	-3.49%	-0.32%
Other Income/Expense, Net
YoY Change
Pretax Income	$813.2M	$100.3M	$120.5M
YoY Change	574.85%	-17.92%	34.04%
Income Tax	$266.2M	$25.20M	$27.20M
% Of Pretax Income	32.73%	25.12%	22.57%
Net Earnings	$547.0M	$75.10M	$93.30M
YoY Change	486.28%	-17.56%	37.61%
Net Earnings / Revenue	95.11%	14.01%	18.04%
Basic Earnings Per Share	$2.59	$0.69	$0.83
Diluted Earnings Per Share	$2.55	$0.68	$0.81
COMMON SHARES
Basic Shares Outstanding	105.6M shares	109.4M shares	112.6M shares
Diluted Shares Outstanding	107.4M shares		114.7M shares

Balance Sheet

Concept	2014 Q2	2013 Q4	2013 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.484B	$936.9M	$575.0M
YoY Change	158.1%	79.69%	13.64%
Cash & Equivalents	$498.6M	$420.4M	$372.7M
Short-Term Investments	$985.5M	$516.5M	$202.3M
Other Short-Term Assets	$60.30M	$71.80M	$97.70M
YoY Change	-38.28%	25.96%	2.3%
Inventory	$317.1M	$308.9M	$299.5M
Prepaid Expenses	$46.30M	$46.80M	$42.70M
Receivables	$327.5M	$302.5M	$341.8M
Other Receivables	$0.00	$25.50M	$0.00
Total Short-Term Assets	$2.278B	$1.726B	$1.391B
YoY Change	63.82%	33.59%	8.74%
LONG-TERM ASSETS
Property, Plant & Equipment	$422.5M	$421.6M	$399.2M
YoY Change	5.84%	12.94%	26.41%
Goodwill	$384.3M	$385.4M	$381.5M
YoY Change	0.73%	0.18%	9.06%
Intangibles	$29.50M	$33.50M	$64.60M
YoY Change	-54.33%	-50.0%	4.7%
Long-Term Investments	$10.90M	$11.40M	$11.50M
YoY Change	-5.22%	-0.87%	-12.88%
Other Assets	$35.70M	$35.40M	$25.40M
YoY Change	40.55%	34.6%	-1.55%
Total Long-Term Assets	$1.049B	$984.1M	$949.1M
YoY Change	10.47%	5.86%	19.19%
TOTAL ASSETS
Total Short-Term Assets	$2.278B	$1.726B	$1.391B
Total Long-Term Assets	$1.049B	$984.1M	$949.1M
Total Assets	$3.327B	$2.710B	$2.340B
YoY Change	42.18%	21.99%	12.75%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$533.4M	$48.40M	$314.2M
YoY Change	69.76%	-35.21%	10.52%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$540.5M	$345.6M	$314.2M
YoY Change	72.02%	-0.52%	10.52%
LONG-TERM LIABILITIES
Long-Term Debt	$598.0M	$593.1M	$227.3M
YoY Change	163.09%	213.31%	22.8%
Other Long-Term Liabilities	$273.2M	$226.8M	$218.4M
YoY Change	25.09%	139.24%	27.64%
Total Long-Term Liabilities	$871.2M	$819.9M	$218.4M
YoY Change	298.9%	188.6%	27.64%
TOTAL LIABILITIES
Total Short-Term Liabilities	$540.5M	$345.6M	$314.2M
Total Long-Term Liabilities	$871.2M	$819.9M	$218.4M
Total Liabilities	$1.412B	$1.166B	$759.9M
YoY Change	85.77%	84.56%	18.64%
SHAREHOLDERS EQUITY
Retained Earnings	$2.638B	$2.031B	$1.893B
YoY Change	39.37%	22.79%	26.73%
Common Stock	$874.5M	$797.2M	$740.5M
YoY Change	18.1%	30.01%	36.88%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$1.557B	$1.256B	$1.006B
YoY Change	54.79%	67.49%	83.17%
Treasury Stock Shares	21.10M shares	16.70M shares	13.20M shares
Shareholders Equity	$1.915B	$1.544B	$1.580B
YoY Change
Total Liabilities & Shareholders Equity	$3.327B	$2.710B	$2.340B
YoY Change	42.18%	21.99%	12.75%

Cashflow Statement

Concept	2014 Q2	2013 Q4	2013 Q2
OPERATING ACTIVITIES
Net Income	$547.0M	$75.10M	$93.30M
YoY Change	486.28%	-17.56%	37.61%
Depreciation, Depletion And Amortization	$16.10M	$13.00M	$14.70M
YoY Change	9.52%	-13.91%	5.0%
Cash From Operating Activities	$778.0M	$111.3M	$128.1M
YoY Change	507.34%	-11.95%	-12.74%
INVESTING ACTIVITIES
Capital Expenditures	-$16.00M	-$20.60M	-$29.50M
YoY Change	-45.76%	-63.08%	4.61%
Acquisitions
YoY Change
Other Investing Activities	-$454.4M	-$226.3M	-$43.50M
YoY Change	944.6%	-416.5%	200.0%
Cash From Investing Activities	-$470.4M	-$246.9M	-$73.00M
YoY Change	544.38%	-1672.61%	70.96%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-103.8M	80.50M	-89.30M
YoY Change	16.24%	-154.8%	1650.98%
NET CHANGE
Cash From Operating Activities	778.0M	111.3M	128.1M
Cash From Investing Activities	-470.4M	-246.9M	-73.00M
Cash From Financing Activities	-103.8M	80.50M	-89.30M
Net Change In Cash	203.8M	-55.10M	-34.20M
YoY Change	-695.91%	1047.92%	-134.55%
FREE CASH FLOW
Cash From Operating Activities	$778.0M	$111.3M	$128.1M
Capital Expenditures	-$16.00M	-$20.60M	-$29.50M
Free Cash Flow	$794.0M	$131.9M	$157.6M
YoY Change	403.81%	-27.61%	-9.94%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="FONT-FAMILY: times;"><font size="2"><b>Cash Flow Statement Revision</b></font></p> <p style="FONT-FAMILY: times;"><font size="2">        In preparing the consolidated financial statements for the year ended December 31, 2013, the Company determined that it had misclassified certain accrued capital expenditures in the consolidated condensed statements of cash flows for the six months ended June 30, 2013. The Company has evaluated and concluded that this did not result in a material misstatement of the Company's previously issued consolidated financial statements. However, the Company has elected to revise its consolidated condensed statement of cash flows for the six months ended June 30, 2013 to correct the presentation of accrued capital expenditures, resulting in an increase to net cash used in investing activities (with a corresponding increase to net cash provided by operating activities) of $14.9 million.</font></p> </div>
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	1544400000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	244600000	USD
CY2013Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	186600000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	369000000	USD
CY2013Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	33500000	USD
CY2013Q4	us-gaap	Assets Assets	2709900000	USD
CY2013Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	2030800000	USD
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2709900000	USD
CY2013Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	123600000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	79000000	USD
CY2013Q2	ew	Intellectual Property Litigation Income Expense Net IntellectualPropertyLitigationIncomeExpenseNet	-5500000	USD
CY2014Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	547000000	USD
CY2014Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	60400000	USD
CY2013Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	57800000	USD
CY2014Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	79100000	USD
CY2013Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	82200000	USD
CY2014Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	177600000	USD
CY2013Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	168900000	USD
CY2014Q2	us-gaap	Inventory Net InventoryNet	317100000	USD
CY2014Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	151200000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	297100000	USD
CY2014Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	215500000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	412700000	USD
	ew	Intellectual Property Litigation Income Expense Net IntellectualPropertyLitigationIncomeExpenseNet	72600000	USD
CY2013Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	35400000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	607300000	USD
CY2013Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	120500000	USD
CY2014Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	311100000	USD
CY2014Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	813200000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	890500000	USD
CY2013Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	27200000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	73900000	USD
CY2014Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	266200000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	283200000	USD
CY2013Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	93300000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	237200000	USD
CY2013Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.83
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.09
CY2014Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	5.18
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	5.72
CY2013Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.81
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.05
CY2014Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	5.09
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	5.63
CY2013Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	97300000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	227100000	USD
CY2014Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	538300000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	593800000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	28800000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	32300000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-25200000	USD
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-300000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	10800000	USD
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-3700000	USD
	dei	Entity Registrant Name EntityRegistrantName	Edwards Lifesciences Corp
	dei	Entity Central Index Key EntityCentralIndexKey	0001099800
	dei	Document Type DocumentType	10-Q
	dei	Document Period End Date DocumentPeriodEndDate	2014-06-30
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2014Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	106033418	shares
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2014
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
CY2013Q4	us-gaap	Equity Method Investment Aggregate Cost EquityMethodInvestmentAggregateCost	14100000	USD
CY2014Q2	ew	Cumulative Income Loss From Equity Method Investments CumulativeIncomeLossFromEquityMethodInvestments	-1500000	USD
CY2014Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-5400000	USD
CY2013Q4	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	516500000	USD
CY2013Q4	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	516500000	USD
CY2014Q2	ew	Held To Maturity Securities Debt Maturities Next Rolling Twelve Months Amortized Cost Basis HeldToMaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis	985500000	USD
CY2014Q2	ew	Held To Maturity Securities Debt Maturities Rolling Year Two Through Five Amortized Cost Basis HeldToMaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis	63600000	USD
CY2014Q2	us-gaap	Held To Maturity Securities Debt Maturities Without Single Maturity Date Net Carrying Amount HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateNetCarryingAmount	17300000	USD
CY2014Q2	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	1066400000	USD
CY2014Q2	us-gaap	Held To Maturity Securities Debt Maturities Next Rolling Twelve Months Fair Value HeldToMaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue	985500000	USD
CY2014Q2	us-gaap	Held To Maturity Securities Debt Maturities Rolling Year Two Through Five Fair Value HeldToMaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue	63700000	USD
CY2014Q2	us-gaap	Held To Maturity Securities Debt Maturities Without Single Maturity Date Fair Value HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue	17300000	USD
CY2014Q2	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	1066500000	USD
CY2014Q2	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	400000	USD
CY2013Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	400000	USD
CY2014Q2	ew	Available For Sale Securities Accumulated Gross Unrealized Gain Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainLossBeforeTax	100000	USD
CY2013Q4	ew	Available For Sale Securities Accumulated Gross Unrealized Gain Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainLossBeforeTax	400000	USD
CY2014Q2	us-gaap	Available For Sale Securities Equity Securities Noncurrent AvailableForSaleSecuritiesEquitySecuritiesNoncurrent	500000	USD
CY2013Q4	us-gaap	Available For Sale Securities Equity Securities Noncurrent AvailableForSaleSecuritiesEquitySecuritiesNoncurrent	800000	USD
CY2014Q2	us-gaap	Equity Method Investment Aggregate Cost EquityMethodInvestmentAggregateCost	12400000	USD
CY2013Q4	ew	Cumulative Income Loss From Equity Method Investments CumulativeIncomeLossFromEquityMethodInvestments	-2700000	USD
CY2014Q2	us-gaap	Equity Method Investments EquityMethodInvestments	10900000	USD
CY2013Q4	us-gaap	Equity Method Investments EquityMethodInvestments	11400000	USD
CY2014Q2	us-gaap	Cost Method Investments CostMethodInvestments	6700000	USD
CY2013Q4	us-gaap	Cost Method Investments CostMethodInvestments	9700000	USD
CY2014Q2	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	18100000	USD
CY2013Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	21900000	USD
CY2014Q1	us-gaap	Costmethod Investments Other Than Temporary Impairment CostmethodInvestmentsOtherThanTemporaryImpairment	3500000	USD
CY2013Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2500000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4100000	USD
	us-gaap	Maximum Length Of Time Foreign Currency Cash Flow Hedge MaximumLengthOfTimeForeignCurrencyCashFlowHedge	P13M
	us-gaap	Cash Flow Hedge Gain Loss To Be Reclassified Within Twelve Months CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths	-2800000	USD
CY2014Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	240200000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	235600000	USD
CY2014Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	210700000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	206700000	USD
CY2014Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	29500000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	28900000	USD
CY2014Q2	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	240200000	USD
CY2013Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	240200000	USD
CY2014Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	29500000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5000000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	8500000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	7800000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	7600000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	6900000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	1600000	USD
CY2014Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	105600000	shares
CY2014Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	11900000	USD
CY2013Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	12800000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	23900000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	24000000	USD
CY2014Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	100800000	USD
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P32M
CY2013Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	112600000	shares
CY2013Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-27600000	USD
CY2014Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-41100000	USD
	us-gaap	Other Comprehensive Income Loss Before Reclassifications Before Tax OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax	-10900000	USD
	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax	7700000	USD
	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	-5100000	USD
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	106100000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	113300000	shares
CY2013Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	4600000	USD
CY2014Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1800000	shares
CY2014Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	107400000	shares
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-6200000	USD
CY2013Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2100000	shares
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations	-900000	USD
	us-gaap	Other Nonrecurring Income Expense OtherNonrecurringIncomeExpense	57500000	USD
CY2013Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	114700000	shares
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-19600000	USD
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1800000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	107900000	shares
CY2014Q2	us-gaap	Other Comprehensive Income Derivatives Qualifying As Hedges Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent	-3400000	USD
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2300000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	115600000	shares
CY2014Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.327	pure
CY2013Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.226	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.318	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.238	pure
	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	8400000	USD
CY2014Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	172000000	USD
CY2013Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	127700000	USD
CY2014Q2	ew	Reduction In Liabilities For Unrecognized Tax Benefits ReductionInLiabilitiesForUnrecognizedTaxBenefits	30300000	USD
CY2013Q4	ew	Reduction In Liabilities For Unrecognized Tax Benefits ReductionInLiabilitiesForUnrecognizedTaxBenefits	30900000	USD
CY2014Q2	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	141700000	USD
CY2013Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	96800000	USD
CY2013Q2	us-gaap	Other Comprehensive Income Derivatives Qualifying As Hedges Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent	-200000	USD
	us-gaap	Other Comprehensive Income Derivatives Qualifying As Hedges Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent	-7400000	USD
CY2013Q4	us-gaap	Treasury Stock Value TreasuryStockValue	1256000000	USD
CY2013Q4	us-gaap	Accounts Receivable Net Noncurrent AccountsReceivableNetNoncurrent	7300000	USD
CY2014Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	598000000	USD
	us-gaap	Other Comprehensive Income Derivatives Qualifying As Hedges Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent	9900000	USD
CY2014Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-3100000	USD
CY2013Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-400000	USD
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-6600000	USD
CY2014Q2	ew	Intellectual Property Litigation Income Expense Net IntellectualPropertyLitigationIncomeExpenseNet	747400000	USD
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-200000	USD
CY2014Q2	us-gaap	Sales Revenue Net SalesRevenueNet	575100000	USD
CY2013Q2	us-gaap	Sales Revenue Net SalesRevenueNet	517200000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	1097500000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	1013900000	USD
CY2014Q2	us-gaap	Noncurrent Assets NoncurrentAssets	458200000	USD
CY2013Q4	us-gaap	Noncurrent Assets NoncurrentAssets	457000000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	420400000	USD
CY2013Q4	us-gaap	Short Term Investments ShortTermInvestments	516500000	USD
CY2013Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	328000000	USD
CY2013Q4	us-gaap	Inventory Net InventoryNet	308900000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Liabilities Net Current DeferredTaxAssetsLiabilitiesNetCurrent	33400000	USD
CY2013Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	46800000	USD
CY2013Q4	us-gaap	Other Assets Current OtherAssetsCurrent	71800000	USD
CY2013Q4	us-gaap	Assets Current AssetsCurrent	1725800000	USD
CY2013Q4	us-gaap	Long Term Investments LongTermInvestments	21900000	USD
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	421600000	USD
CY2013Q4	us-gaap	Goodwill Goodwill	385400000	USD
CY2014Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	498600000	USD
CY2014Q2	us-gaap	Short Term Investments ShortTermInvestments	985500000	USD
CY2014Q2	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	327500000	USD
CY2014Q2	us-gaap	Deferred Tax Assets Liabilities Net Current DeferredTaxAssetsLiabilitiesNetCurrent	42800000	USD
CY2014Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	46300000	USD
CY2014Q2	us-gaap	Other Assets Current OtherAssetsCurrent	60300000	USD
CY2014Q2	us-gaap	Assets Current AssetsCurrent	2278100000	USD
CY2014Q2	us-gaap	Accounts Receivable Net Noncurrent AccountsReceivableNetNoncurrent	7600000	USD
CY2014Q2	us-gaap	Long Term Investments LongTermInvestments	99000000	USD
CY2014Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	422500000	USD
CY2014Q2	us-gaap	Goodwill Goodwill	384300000	USD
CY2014Q2	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	69900000	USD
CY2014Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	35700000	USD
CY2014Q2	us-gaap	Assets Assets	3326600000	USD
CY2014Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	540500000	USD
CY2013Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	345600000	USD
CY2014Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	273200000	USD
CY2013Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	593100000	USD
CY2013Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	226800000	USD
CY2013Q4	us-gaap	Preferred Stock Value PreferredStockValue		USD
CY2013Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q2	us-gaap	Preferred Stock Value PreferredStockValue		USD
CY2014Q2	us-gaap	Common Stock Value CommonStockValue	127100000	USD
CY2013Q4	us-gaap	Common Stock Value CommonStockValue	126000000	USD
CY2014Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	747400000	USD
CY2013Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	671200000	USD
CY2014Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	2638100000	USD
CY2014Q2	us-gaap	Treasury Stock Value TreasuryStockValue	1556600000	USD
CY2014Q2	us-gaap	Stockholders Equity StockholdersEquity	1914900000	USD
CY2014Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3326600000	USD
CY2014Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	5600000	USD
CY2013Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	5400000	USD
CY2014Q2	us-gaap	Allowance For Doubtful Accounts Receivable Noncurrent AllowanceForDoubtfulAccountsReceivableNoncurrent	6700000	USD
CY2013Q4	us-gaap	Allowance For Doubtful Accounts Receivable Noncurrent AllowanceForDoubtfulAccountsReceivableNoncurrent	6800000	USD
CY2014Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2013Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2014Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2013Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2014Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2013Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2014Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	1.00
CY2013Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	1.00
CY2014Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	350000000	shares
CY2013Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	350000000	shares
CY2014Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	127100000	shares
CY2013Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	126000000	shares
CY2014Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	106000000	shares
CY2013Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	109300000	shares
CY2014Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	21100000	shares
CY2013Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	16700000	shares
CY2014Q2	us-gaap	Gross Profit GrossProfit	423900000	USD
CY2013Q2	us-gaap	Gross Profit GrossProfit	393600000	USD
	us-gaap	Gross Profit GrossProfit	800400000	USD
	us-gaap	Gross Profit GrossProfit	769300000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	160300000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	174900000	USD
CY2013Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	80500000	USD
CY2014Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	89100000	USD
CY2014Q2	us-gaap	Other Nonrecurring Income Expense OtherNonrecurringIncomeExpense	50000000	USD
CY2014Q2	ew	Other Income Expense OtherIncomeExpense	-400000	USD
CY2013Q2	ew	Other Income Expense OtherIncomeExpense	-100000	USD
	ew	Other Income Expense OtherIncomeExpense	-100000	USD
	ew	Other Income Expense OtherIncomeExpense	-1300000	USD
CY2014Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-8700000	USD
CY2013Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	4000000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-13500000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-10100000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	23900000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	24000000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	21300000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	58900000	USD
	ew	Special Gains Charges Cash Flows Impact SpecialGainsChargesCashFlowsImpact	-7500000	USD
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-3300000	USD
	us-gaap	Gain Loss On Investments GainLossOnInvestments	400000	USD
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-2000000	USD
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-700000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	2000000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-800000	USD
	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	200000	USD
	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	8700000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	11500000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	31700000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	282700000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	11900000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	916900000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	229200000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	30300000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	66300000	USD
	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	1146500000	USD
	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	222000000	USD
	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	594900000	USD
	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	230900000	USD
	ew	Payments To Acquire Proceeds From Sale Of Trading Securities Heldforinvestment PaymentsToAcquireProceedsFromSaleOfTradingSecuritiesHeldforinvestment	10900000	USD
	ew	Payments To Acquire Proceeds From Sale Of Trading Securities Heldforinvestment PaymentsToAcquireProceedsFromSaleOfTradingSecuritiesHeldforinvestment	200000	USD
	ew	Payments For Proceeds From Interest In Subsidiaries And Affiliates PaymentsForProceedsFromInterestInSubsidiariesAndAffiliates	1300000	USD
	ew	Payments For Proceeds From Interest In Subsidiaries And Affiliates PaymentsForProceedsFromInterestInSubsidiariesAndAffiliates	-1600000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-1300000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	100000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-590200000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-59300000	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	214100000	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	332200000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	212900000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	292000000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	300600000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	246600000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	21300000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	58900000	USD
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	32900000	USD
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	27400000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-2400000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	5900000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-247600000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-114200000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations	6100000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	78200000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	61800000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	8200000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	2900000	USD
CY2013Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	372700000	USD
CY2014Q2	ew	Held To Maturity Securities Accumulated Unrecognized Holding Gain HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain	100000	USD
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.013	pure
	ew	Intellectual Property Litigation Income Expense Net IntellectualPropertyLitigationIncomeExpenseNet	741900000	USD
CY2014Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-200000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-200000	USD
CY2013Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-400000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-400000	USD
CY2014Q2	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Writedown Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForWritedownOfSecuritiesNetOfTax	300000	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Writedown Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForWritedownOfSecuritiesNetOfTax	300000	USD
	us-gaap	Income Tax Reconciliation Tax Contingencies Other IncomeTaxReconciliationTaxContingenciesOther	-6200000	USD

Files In Submission

Name	View Source	Status
0001047469-14-006621-index-headers.html	Edgar Link	pending
0001047469-14-006621-index.html	Edgar Link	pending
0001047469-14-006621.txt	Edgar Link	pending
0001047469-14-006621-xbrl.zip	Edgar Link	pending
a2220912z10-q.htm	Edgar Link	pending
a2220912zex-10_2.htm	Edgar Link	pending
a2220912zex-31_1.htm	Edgar Link	pending
a2220912zex-31_2.htm	Edgar Link	pending
a2220912zex-32.htm	Edgar Link	pending
ew-20140630.xml	Edgar Link	completed
ew-20140630.xsd	Edgar Link	pending
ew-20140630_cal.xml	Edgar Link	unprocessable
ew-20140630_def.xml	Edgar Link	unprocessable
ew-20140630_lab.xml	Edgar Link	unprocessable
ew-20140630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$EW
Edwards Lifesciences Corp Stock $ew

2014 Q2 Form 10-Q Financial Statement

#000104746914006621 Filed on August 04, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EW Edwards Lifesciences Corp Stock $ew

2014 Q2 Form 10-Q Financial Statement

#000104746914006621 Filed on August 04, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EW
Edwards Lifesciences Corp Stock $ew